Name (Synonyms) | Correlation | |
---|---|---|
drug2440 | Taking biological samples Wiki | 1.00 |
drug2314 | Standard care Wiki | 0.38 |
Name (Synonyms) | Correlation | |
---|---|---|
D011665 | Pulmonary Valve Insufficiency NIH | 0.41 |
D008171 | Lung Diseases, NIH | 0.26 |
D013577 | Syndrome NIH | 0.11 |
D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.10 |
D012128 | Respiratory Distress Syndrome, Adult NIH | 0.09 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0010444 | Pulmonary insufficiency HPO | 0.41 |
HP:0002088 | Abnormal lung morphology HPO | 0.26 |
There is one clinical trial.
Prone positioning is an established intervention in mechanically ventilated acute respiratory distress syndrome (ARDS) patients, with demonstrated reductions in mortality. Preliminary data suggest that awake proning in patients with COVID-19 treated with high-flow nasal oxygenation (HFNO) improves gas exchanges, and might be associated with a reduced need of mechanical ventilation, and reduced mortality. Further investigation in a formal randomized-controlled trial is need.
Description: Total time spent in prone position, as recorded by nursing or respiratory therapists
Measure: Time in prone position Time: Up to 28 days post randomizationDescription: Daily evolution of oxygenation
Measure: Oxygenation (SpO2/FiO2 ratio) Time: Until HFNC weaning, or up to 14 days after randomization, whichever is first